Publication:
Loss of heterozygosity on chromosome 11 in cervical carcinomas

dc.contributor.authorKacar, K. (12647164500)
dc.contributor.authorNovakovic, I. (6603235567)
dc.contributor.authorPopovic-Kuzmanovic, D. (6505909047)
dc.contributor.authorMilasin, J. (6603015594)
dc.contributor.authorLukovic, Lj. (6603898552)
dc.contributor.authorJekic, B. (6603561846)
dc.contributor.authorBunjevacki, V. (6506110754)
dc.contributor.authorKrajinovic, M. (7004106736)
dc.contributor.authorOstojic, N. (6701663928)
dc.date.accessioned2025-07-02T12:54:40Z
dc.date.available2025-07-02T12:54:40Z
dc.date.issued2000
dc.description.abstractThe aim of this study was to detect the loss of putative tumor suppressor genes (TSG) mapping on chromosome 11 in a series of 15 cervical carcinomas. Highly polymorphic microsatellite markers mapping on the selected regions on 11p (11p12 and 11p15.2), and 11q (11q13 and 11q23) were amplified by PCR and used to detect the loss of heterozygosity in our sample. All the tumors were squamous cell carcinomas with various degrees of differentiation. We found that 3 out of 15 cases showed LOH of at least one microsatellite locus on chromosome 11p. LOH on chromosome 11q occurred in 4 samples. All the tumors except one were histologic grade 2, but had heterogeneous clinical stages. The overall incidence of LOH on 11p and 11q in our sample was 18,5% and 29%, respectively. These results might suggest the presence of new tumor suppressor genes (except the well-known WT1) within these chromosomal regions as well as their involvement in cervical carcinogenesis.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0034455077&partnerID=40&md5=711b5429410798428d03fb6867a4b31c
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/14503
dc.subjectCervical carcinoma
dc.subjectChromosome 11
dc.subjectLOH
dc.titleLoss of heterozygosity on chromosome 11 in cervical carcinomas
dspace.entity.typePublication

Files